Colgate-Palmolive Company CL
- Market cap
- $68.3B
- P/E
- 33.9×
Follow CL
Colgate-Palmolive Company (CL) EV/EBITDA
As of 25 September 2026, Colgate-Palmolive Company (CL) trades at a EV/EBITDA of 16.0×. Over the past ten years it has ranged from 13.3× (October 2018) to 22.4× (September 2016); the current reading is higher than 32% of that period. That is above the Household & Personal Products industry median of 12.3× and above the Consumer Defensive sector median of 9.4×.
EV/EBITDA, daily
Annual
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 14.5× | (12.85%) |
| FY2024 | 16.7× | 2.12% |
| FY2023 | 16.3× | (8.36%) |
| FY2022 | 17.8× | 1.31% |
| FY2021 | 17.6× | (2.32%) |
| FY2020 | 18.0× | 11.47% |
| FY2019 | 16.2× | 16.50% |
| FY2018 | 13.9× | (19.62%) |
| FY2017 | 17.3× | 17.60% |
| FY2016 | 14.7× | (27.63%) |
Quarterly
| Period | EV/EBITDA | Change |
|---|---|---|
| Jun 2026 | 17.0× | 7.70% |
| Mar 2026 | 15.8× | 8.58% |
| Dec 2025 | 14.5× | (0.96%) |
| Sep 2025 | 14.7× | (11.71%) |
| 42 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| UL Unilever PLC compare | 0.8× |
| KMB Kimberly-Clark Corporation compare | 11.8× |
| CLX The Clorox Company compare | 12.1× |
| KVUE Kenvue Inc. compare | 12.6× |
| PG Procter & Gamble Company (The) compare | 16.0× |
| CL Colgate-Palmolive Company | 16.0× |
| CHD Church & Dwight Co., Inc. compare | 18.4× |
| EL The Estee Lauder Companies Inc. compare | 24.1× |
| ELF e.l.f. Beauty compare | 28.9× |
| Household & Personal Products industry median | 12.3× |
| Consumer Defensive sector median | 9.4× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on CL
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement